Enzon Pharmaceuticals (ENZN) Stock Price, Quote, News and Overview
NASDAQ:ENZN - Nasdaq -
ENZN Quote, Performance and Key Statistics
0.46
+0.01 (+2.22%)
The current stock price of ENZN is 0.46 null. In the past month the price decreased by -8%. In the past year, price decreased by -62.3%.
About ENZN
Company Profile
Enzon Pharmaceuticals, Inc. is a biotechnology company. It discovers, develops, and commercializes therapeutics to treat life-threatening diseases. The Company's marketed drug products include PegIntron (R) for chronic hepatitis C; Sylatron (R) for Melanoma; Macugen (R) for neovascular age-related macular degeneration; CIMZIA (R) for Crohn's disease; Oncaspar for acute lymphoblastic leukemia; and Adagen for severe combined immunedeficiency. Enzon Pharmaceuticals, Inc. is headquartered in Piscataway, New Jersey.
Company Info
Enzon Pharmaceuticals
20 Commerce Drive Suite 135
Cranford NJ 07016
CEO: Andrew Rackear
Phone: 732-980-4500
Enzon Pharmaceuticals / ENZN FAQ
What is the stock price of Enzon Pharmaceuticals today?
The current stock price of ENZN is 0.46 null. The price increased by 2.22% in the last trading session.
What is the ticker symbol for Enzon Pharmaceuticals stock?
The exchange symbol of Enzon Pharmaceuticals is ENZN and it is listed on the Nasdaq exchange.
On which exchange is ENZN stock listed?
ENZN stock is listed on the Nasdaq exchange.
What is Enzon Pharmaceuticals worth?
Enzon Pharmaceuticals (ENZN) has a market capitalization of 20.34M null. This makes ENZN a Nano Cap stock.
What are the support and resistance levels for Enzon Pharmaceuticals (ENZN) stock?
Enzon Pharmaceuticals (ENZN) has a support level at 0.44 and a resistance level at 0.49. Check the full technical report for a detailed analysis of ENZN support and resistance levels.
Should I buy Enzon Pharmaceuticals (ENZN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ENZN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ENZN, evaluating the profitability, health, valuation and growth aspects
- Enzon Pharmaceuticals (ENZN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Enzon Pharmaceuticals (ENZN) Sales and EPS estimates to see what analysts future expectations are.
- Enzon Pharmaceuticals (ENZN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Enzon Pharmaceuticals (ENZN) Insider and Institutional Ownership to learn about the owners and their transactions.
- Enzon Pharmaceuticals (ENZN) Stock Chart to make your own analysis
- Enzon Pharmaceuticals (ENZN) Latest news and press-releases to stay up to date.
Does Enzon Pharmaceuticals (ENZN) stock pay dividends?
Enzon Pharmaceuticals (ENZN) has a dividend yield of 38.46%. The yearly dividend amount is currently 0.15. Check the full fundamental report for a detailed analysis of ENZN dividend history, reliability and sustainability.
What is the Price/Earnings (PE) ratio of Enzon Pharmaceuticals (ENZN)?
Enzon Pharmaceuticals (ENZN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.05).
What is the Short Interest ratio of Enzon Pharmaceuticals (ENZN) stock?
The outstanding short interest for Enzon Pharmaceuticals (ENZN) is 0.01% of its float. Check the ownership tab for more information on the ENZN short interest.
ENZN Technical Analysis
ENZN Financial Highlights
Over the last trailing twelve months ENZN reported a non-GAAP Earnings per Share(EPS) of -0.05.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 100.07% | ||
| ROA | -12.28% | ||
| ROE | -12.58% | ||
| Debt/Equity | 0 |